| 2026-04-27 21:06 | CC:NRX | Nurexone Biologic Inc | 0.61 | News Release200 | Nurexone granted patent by IP Australia |
| 2026-04-16 19:47 | CC:NRX | Nurexone Biologic Inc | 0.65 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2026-04-16 19:47 | CC:NRX | Nurexone Biologic Inc | 0.65 | SEDAR MD & A815 | SEDAR MD & A |
| 2026-04-16 09:15 | CC:NRX | NurExone Biologic Inc. | 0.65 | News Release200 | NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update |
| 2026-04-15 19:38 | CC:NRX | Nurexone Biologic Inc | 0.65 | Private Placement250 | Nurexone Biologic 1,295,222-share private placement |
| 2026-04-10 16:04 | CC:NRX | NurExone Biologic Inc. | 0.63 | News Release200 | NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026 |
| 2026-04-07 20:43 | CC:NRX | Nurexone Biologic Inc | 0.67 | News Release200 | Nurexone's Exo-Top signs LOI with BioXtek |
| 2026-04-01 09:17 | CC:NRX | NurExone Biologic Inc. | 0.61 | News Release200 | NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy |
| 2026-03-26 19:02 | CC:NRX | Nurexone Biologic Inc | 0.60 | News Release200 | Nurexone subsidiaries sign sublicence agreements |
| 2026-03-11 19:53 | CC:NRX | Nurexone Biologic Inc | 0.58 | News Release200 | Nurexone signs consulting agreement, closes financing |
| 2026-02-27 16:03 | CC:NRX | NurExone Biologic Inc. | 0.66 | News Release200 | NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update |
| 2026-02-10 16:04 | CC:NRX | NurExone Biologic Inc. | 0.64 | News Release200 | NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production |
| 2026-01-30 17:29 | CC:NRX | Nurexone Biologic Inc | 0.66 | News Release200 | Nurexone Biologic appoints Gabbai director |
| 2025-12-19 16:04 | CC:NRX | NurExone Biologic Inc. | 0.69 | News Release200 | NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis |
| 2025-12-12 17:02 | CC:NRX | Nurexone Biologic Inc | 0.61 | News Release200 | Nurexone prepares small-scale manufacturing for ExoPTEN |
| 2025-11-28 09:15 | CC:NRX | NurExone Biologic Inc. | 0.71 | News Release200 | NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-11-26 17:18 | CC:NRX | Nurexone Biologic Inc | 0.71 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-11-26 17:12 | CC:NRX | Nurexone Biologic Inc | 0.71 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-11-12 22:03 | CC:NRX | Nurexone Biologic Inc | 0.70 | News Release200 | Nurexone receives $3.18-million from warrant exercise |
| 2025-11-04 02:56 | CC:NRX | Nurexone Biologic Inc | 0.69 | News Release200 | Nurexone joins BioFab Startup Lab |
| 2025-10-21 16:04 | CC:NRX | NurExone Biologic Inc. | 0.78 | News Release200 | NurExone Invited Presenter at Precision EV Forum in Cambridge, UK |
| 2025-10-08 18:27 | CC:NRX | Nurexone Biologic Inc | 0.90 | News Release200 | Nurexone shows vision recovery in glaucoma study |
| 2025-09-17 20:52 | CC:NRX | Nurexone Biologic Inc | 1.07 | Private Placement250 | Nurexone Biologic 930,376-share private placement |
| 2025-09-17 04:55 | CC:NRX | Nurexone Biologic Inc | 1.05 | News Release200 | Nurexone to open exosome production facility in Indiana |
| 2025-09-12 01:22 | CC:NRX | Nurexone Biologic Inc | 0.90 | News Release200 | Nurexone Biologic receives patent in Israel |
| 2025-09-09 21:06 | CC:NRX | Nurexone Biologic Inc | 0.84 | Private Placement250 | Nurexone Biologic 1,258,072-share private placement |
| 2025-09-08 16:30 | CC:NRX | NurExone Biologic Inc. | 0.81 | News Release200 | NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness |
| 2025-08-28 08:15 | CC:NRX | NurExone Biologic Inc. | 0.83 | News Release200 | NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results |
| 2025-08-20 19:36 | CC:NRX | Nurexone Biologic Inc | 0.79 | News Release200 | Nurexone releases preclinical ExoPTEN imaging results |
| 2025-08-08 17:30 | CC:NRX | Nurexone Biologic Inc | 0.69 | News Release200 | Nurexone says exosomes beat industry healing standard |
| 2025-07-08 16:24 | CC:NRX | NurExone Biologic Inc. | 0.67 | News Release200 | New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model |
| 2025-06-20 10:16 | CC:NRX | Nurexone Biologic Inc | 0.67 | News Release200 | Nurexone Biologic joins HealthTech Hub program |
| 2025-06-04 19:38 | CC:NRX | Nurexone Biologic Inc | 0.71 | News Release200 | Nurexone presents at conference, to hold AGM June 18 |
| 2025-05-30 18:01 | CC:NRX | Biologic Inc | 0.68 | News Release200 | Nurexone Biologic adviser to present at ASIA meeting |
| 2025-05-27 08:59 | CC:NRX | NurExone Biologic Inc. | 0.66 | News Release200 | NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-05-27 08:42 | CC:NRX | Nurexone Biologic Inc | 0.66 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-05-27 08:42 | CC:NRX | Nurexone Biologic Inc | 0.66 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |